hematopoietic system
• plasma cell formation is severely impeded 10 days after primary and secondary immunization
|
• mice show increased numbers of germinal center B cells at day 10 after primary immunizations
|
• small, but significant, increase of the fraction of germinal center B cells in the S and G2 phases of the cell cycle
|
• reduction in total as well as sheep red blood cell-specific IgG1, but not IgM, antibodies 10 days after primary and secondary immunization
|
immune system
• plasma cell formation is severely impeded 10 days after primary and secondary immunization
|
• mice show increased numbers of germinal center B cells at day 10 after primary immunizations
|
• small, but significant, increase of the fraction of germinal center B cells in the S and G2 phases of the cell cycle
|
• reduction in total as well as sheep red blood cell-specific IgG1, but not IgM, antibodies 10 days after primary and secondary immunization
|
mortality/aging
• shortened survival, with 40% survival at around 500 days of age
|
neoplasm
• mice succumb to a B cell-derived lymphoproliferative disease affecting spleen and lymph nodes, resembling human diffuse large B cell lymphoma
• mice develop clonal lymphomas consistent with activated B cell-diffuse large B cell lymphoma
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
non-Hodgkin lymphoma | DOID:0060060 |
OMIM:605027 |
J:167612 |